Patel, R., Emanuel, M., Young, R., Hill, E. M. (2026). A phase 1b/2 study of mirdametinib in combination with sirolimus for patients with RAS-mutated relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps7582